Literature DB >> 32647637

Comparison of Safety and Efficacy of Yttrium-90 Radioembolization for Nonalcoholic Fatty Liver Disease-Associated and Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Lei Liang1,2, Li-Yang Sun1,2, Yong-Kang Diao1,2, Tian Yang1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32647637      PMCID： PMC7325134          DOI： 10.1159/000506353

Source DB:  PubMed          Journal:  Liver Cancer        ISSN： 1664-5553            Impact factor:   11.740


× No keyword cloud information.
  4 in total

1.  Using Propensity Score Methods to Create Target Populations in Observational Clinical Research.

Authors:  Laine Thomas; Fan Li; Michael Pencina
Journal:  JAMA       Date:  2020-01-10       Impact factor: 56.272

2.  Liver Resection for Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: a Multicenter Propensity Matching Analysis with HBV-HCC.

Authors:  Tian Yang; Lun-Yang Hu; Zhen-Li Li; Kai Liu; Han Wu; Hao Xing; Wan Yee Lau; Timothy M Pawlik; Yong-Yi Zeng; Ya-Hao Zhou; Wei-Min Gu; Hong Wang; Ting-Hao Chen; Jun Han; Chao Li; Ming-Da Wang; Meng-Chao Wu; Feng Shen
Journal:  J Gastrointest Surg       Date:  2019-01-07       Impact factor: 3.452

3.  The Propensity Score.

Authors:  Jason S Haukoos; Roger J Lewis
Journal:  JAMA       Date:  2015-10-20       Impact factor: 56.272

4.  NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization.

Authors:  Clemens Schotten; Lars P Bechmann; Paul Manka; Jens Theysohn; Alexander Dechêne; Amr El Fouly; Francesco Barbato; Ursula Neumann; Sonia Radünz; Svenja Sydor; Dominik Heider; Marino Venerito; Ali Canbay; Guido Gerken; Ken Herrmann; Heiner Wedemeyer; Jan Best
Journal:  Liver Cancer       Date:  2019-07-29       Impact factor: 11.740
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.